The scientific staff at Saint Joseph's Translational Research Institute (SJTRI) has announced that a new thin, bare metal stent (BMS) has been approved for sale by European Union regulators. Medlogic Device Corporations' COBRA™ Coronary Stent System received the CE Mark based on the chronic preclinical implants performed at SJTRI which demonstrate the safety and efficacy of the stent. Read More

H. Robert Superko, MD, world renowned for his work in genetics and genomics, has joined Saint Joseph’s Translational Research Institute as executive director, Center for Genomics and Human Health.  Dr. Superko and his team will develop and conduct research studies that identify patients’ genetic susceptibility to heart disease, cancer and other chronic disease states and, most importantly, translate those findings into individualized treatment programs based on the person’s unique genetic makeup. Read More